A theme focused on expanding healthcare-related businesses centred on regenerative medicine globally and establishing the business and capital foundations needed to enable the future listing of subsidiaries. This includes achieving the listing of StemCell Institute Inc. and diversifying funding sources through public offerings and share sales.